Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (261-270 of 365) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|October 1, 1996
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationJ J Pink, M M Bilimoria, J Assikis, et al.
Cancer Research|September 15, 1999
The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptorJ I Schafer, H Liu, D A Tonetti, et al.
Cancer Letters|May 5, 1998
Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cellsA S Levenson, K M Svoboda, H C Kwaan, et al.
Molecular and Cellular Endocrinology|February 25, 2000
EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathwayB D Gehm, J M McAndrews, V C Jordan, et al.
Oncogene|August 22, 2012
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancerM Razandi, A Pedram, V C Jordan, et al.
Molecular Pharmacology|November 1, 1990
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitroC S Murphy, S M Langan-Fahey, R McCague, et al.
Cancer Research|February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifenP M Ravdin, N F Fritz, D C Tormey, et al.
Journal of Steroid Biochemistry|June 1, 1986
Effects of antiestrogens on the induction of vitellogenin and its mRNA in Xenopus laevisA T Riegel, V C Jordan, R R Bain, et al.
Environmental Health Perspectives|September 1, 1985
Structure-activity relationships of estrogensV C Jordan, S Mittal, B Gosden, et al.
Cancer|February 15, 1993
The estrogenic activity of synthetic progestins used in oral contraceptivesV C Jordan, M H Jeng, W H Catherino, et al.
Pageof 37

Showing results (261-270 of 365) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|October 1, 1996
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationJ J Pink, M M Bilimoria, J Assikis, et al.
Cancer Research|September 15, 1999
The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptorJ I Schafer, H Liu, D A Tonetti, et al.
Cancer Letters|May 5, 1998
Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cellsA S Levenson, K M Svoboda, H C Kwaan, et al.
Molecular and Cellular Endocrinology|February 25, 2000
EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathwayB D Gehm, J M McAndrews, V C Jordan, et al.
Oncogene|August 22, 2012
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancerM Razandi, A Pedram, V C Jordan, et al.
Molecular Pharmacology|November 1, 1990
Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitroC S Murphy, S M Langan-Fahey, R McCague, et al.
Cancer Research|February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifenP M Ravdin, N F Fritz, D C Tormey, et al.
Journal of Steroid Biochemistry|June 1, 1986
Effects of antiestrogens on the induction of vitellogenin and its mRNA in Xenopus laevisA T Riegel, V C Jordan, R R Bain, et al.
Environmental Health Perspectives|September 1, 1985
Structure-activity relationships of estrogensV C Jordan, S Mittal, B Gosden, et al.
Cancer|February 15, 1993
The estrogenic activity of synthetic progestins used in oral contraceptivesV C Jordan, M H Jeng, W H Catherino, et al.
Pageof 37